• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GCN5L1在心脏缺血再灌注损伤期间抑制丙酮酸脱氢酶磷酸化

GCN5L1 Inhibits Pyruvate Dehydrogenase Phosphorylation During Cardiac Ischemia-Reperfusion Injury.

作者信息

Bugga Paramesha, Stoner Michael W, Manning Janet R, Mushala Bellina A S, Bhattarai Nisha, Sharifi-Sanjani Maryam, Scott Iain

机构信息

Vascular Medicine Institute University of Pittsburgh Pittsburgh Pennsylvania USA.

Center for Metabolism and Mitochondrial Medicine University of Pittsburgh Pittsburgh Pennsylvania USA.

出版信息

FASEB Bioadv. 2025 Sep 12;7(9):e70049. doi: 10.1096/fba.2025-00187. eCollection 2025 Sep.

DOI:10.1096/fba.2025-00187
PMID:40950650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426763/
Abstract

Myocardial infarction remains one of the leading causes of mortality. Reperfusion of the infarcted myocardium restores blood flow and reduces primary ischemic injury. However, despite its protective function, reperfusion is also associated with several deleterious outcomes that can result in ischemia-reperfusion (I/R) injury to cardiac tissue. Although negative outcomes such as reactive oxygen species generation are strongly associated with I/R injury, cardiac energy metabolism is also greatly disrupted. Furthermore, previous studies have shown that the restoration of normal fuel oxidation in the myocardium regulates the extent of contractile recovery. A better understanding of the pathophysiological mechanisms underlying I/R injury may allow us to develop new treatments that limit the negative aspects of the process. In this study, we examined the role played by GCN5L1, a protein implicated in the regulation of energy metabolism, in I/R injury. We demonstrate that cardiac-specific loss of GCN5L1 promotes the inhibitory phosphorylation of pyruvate dehydrogenase in vitro and in vivo, a process likely to inhibit glucose oxidation, and that this corresponds to increased myocardial damage following ischemia-reperfusion (I/R) injury.

摘要

心肌梗死仍然是主要的死亡原因之一。梗死心肌的再灌注可恢复血流并减少原发性缺血性损伤。然而,尽管再灌注具有保护作用,但它也与多种有害后果相关,这些后果可导致心脏组织的缺血再灌注(I/R)损伤。虽然诸如活性氧生成等负面结果与I/R损伤密切相关,但心脏能量代谢也会受到极大干扰。此外,先前的研究表明,心肌中正常燃料氧化的恢复调节收缩恢复的程度。更好地理解I/R损伤背后的病理生理机制可能使我们能够开发出新的治疗方法,以限制该过程的负面影响。在本研究中,我们研究了参与能量代谢调节的蛋白质GCN5L1在I/R损伤中所起的作用。我们证明,GCN5L1的心脏特异性缺失在体外和体内均促进丙酮酸脱氢酶的抑制性磷酸化,这一过程可能抑制葡萄糖氧化,并且这与缺血再灌注(I/R)损伤后心肌损伤增加相对应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/b0494501ac87/FBA2-7-e70049-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/99aa2c4d8991/FBA2-7-e70049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/768643a03b9d/FBA2-7-e70049-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/cda487488b89/FBA2-7-e70049-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/b0494501ac87/FBA2-7-e70049-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/99aa2c4d8991/FBA2-7-e70049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/768643a03b9d/FBA2-7-e70049-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/cda487488b89/FBA2-7-e70049-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7c9/12426763/b0494501ac87/FBA2-7-e70049-g002.jpg

相似文献

1
GCN5L1 Inhibits Pyruvate Dehydrogenase Phosphorylation During Cardiac Ischemia-Reperfusion Injury.GCN5L1在心脏缺血再灌注损伤期间抑制丙酮酸脱氢酶磷酸化
FASEB Bioadv. 2025 Sep 12;7(9):e70049. doi: 10.1096/fba.2025-00187. eCollection 2025 Sep.
2
GCN5L1 inhibits pyruvate dehydrogenase phosphorylation during cardiac ischemia-reperfusion injury.GCN5L1在心脏缺血再灌注损伤期间抑制丙酮酸脱氢酶磷酸化。
bioRxiv. 2025 May 19:2024.06.03.597148. doi: 10.1101/2024.06.03.597148.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
MTX2 facilitates PKM2 tetramerization to promote cardiac glucose metabolism and protects the heart against ischemia/reperfusion injury.MTX2促进丙酮酸激酶M2四聚体化,以促进心脏葡萄糖代谢,并保护心脏免受缺血/再灌注损伤。
Theranostics. 2025 Jun 9;15(14):6737-6752. doi: 10.7150/thno.110162. eCollection 2025.
5
Irisin improves acute kidney injury induced by ischemia-reperfusion through targeting energy metabolism reprogramming.鸢尾素通过靶向能量代谢重编程改善缺血再灌注诱导的急性肾损伤。
Int J Biol Macromol. 2025 Aug 25;323(Pt 2):147073. doi: 10.1016/j.ijbiomac.2025.147073.
6
Advances in macrophage metabolic reprogramming in myocardial ischemia-reperfusion.心肌缺血再灌注中巨噬细胞代谢重编程的研究进展。
Cell Signal. 2024 Nov;123:111370. doi: 10.1016/j.cellsig.2024.111370. Epub 2024 Aug 30.
7
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
8
Ginsenoside Rg1 mitigates cerebral ischaemia/reperfusion injury in mice by inhibiting autophagy through activation of mTOR signalling.人参皂苷 Rg1 通过激活 mTOR 信号通路抑制自噬减轻小鼠脑缺血/再灌注损伤。
Acta Pharmacol Sin. 2024 Dec;45(12):2474-2486. doi: 10.1038/s41401-024-01334-4. Epub 2024 Jun 27.
9
Cardiac ischemia/reperfusion stress reduces inner mitochondrial membrane protein (mitofilin) levels during early reperfusion.心肌缺血/再灌注应激会导致线粒体膜蛋白(mitofilin)水平在再灌注早期降低。
Free Radic Biol Med. 2020 Oct;158:181-194. doi: 10.1016/j.freeradbiomed.2020.06.039. Epub 2020 Jul 26.
10
CD11b Blockade Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Neutrophil and Monocyte Infiltration.CD11b阻断通过减少中性粒细胞和单核细胞浸润改善心肌缺血/再灌注损伤。
J Am Heart Assoc. 2025 Jul;14(13):e038142. doi: 10.1161/JAHA.124.038142. Epub 2025 Jun 27.

本文引用的文献

1
Mitochondrial dysfunction in AMI: mechanisms and therapeutic perspectives.急性心肌梗死中的线粒体功能障碍:机制与治疗前景
J Transl Med. 2025 Apr 10;23(1):418. doi: 10.1186/s12967-025-06406-5.
2
Validation of GCN5L1/BLOC1S1/BLOS1 antibodies using knockout cells and tissue.使用基因敲除细胞和组织验证 GCN5L1/BLOC1S1/BLOS1 抗体。
Biochem J. 2024 May 22;481(10):643-651. doi: 10.1042/BCJ20230302.
3
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
4
GCN5L1 impairs diastolic function in mice exposed to a high fat diet by restricting cardiac pyruvate oxidation.GCN5L1 通过限制心脏丙酮酸氧化来损害高脂饮食暴露小鼠的舒张功能。
Physiol Rep. 2022 Aug;10(15):e15415. doi: 10.14814/phy2.15415.
5
Cardiac Energy Metabolism in Heart Failure.心力衰竭中的心脏能量代谢。
Circ Res. 2021 May 14;128(10):1487-1513. doi: 10.1161/CIRCRESAHA.121.318241. Epub 2021 May 13.
6
Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.心脏细胞中 GCN5L1 的缺失会通过减少 Akt/mTORC2 信号通路来破坏葡萄糖代谢并促进细胞死亡。
Biochem J. 2019 Jun 19;476(12):1713-1724. doi: 10.1042/BCJ20190302.
7
Cardiac-specific deletion of GCN5L1 restricts recovery from ischemia-reperfusion injury.心脏特异性敲除 GCN5L1 限制缺血再灌注损伤的恢复。
J Mol Cell Cardiol. 2019 Apr;129:69-78. doi: 10.1016/j.yjmcc.2019.02.009. Epub 2019 Feb 15.
8
GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.GCN5L1调节线粒体与细胞信号之间的相互作用,以调控FoxO1稳定性和糖异生作用。
Nat Commun. 2017 Sep 12;8(1):523. doi: 10.1038/s41467-017-00521-8.
9
FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.FoxO1通过对丙酮酸脱氢酶激酶4表达的转录调控来调节心肌葡萄糖氧化速率。
Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H479-H490. doi: 10.1152/ajpheart.00191.2017. Epub 2017 Jul 7.
10
Evolving Concepts of Myocardial Energy Metabolism: More Than Just Fats and Carbohydrates.心肌能量代谢的演变概念:不仅仅是脂肪和碳水化合物
Circ Res. 2016 Nov 11;119(11):1173-1176. doi: 10.1161/CIRCRESAHA.116.310078.